MedPath
NMPA Approval

Rituximab Injection

国药准字J20170034

April 28, 2017

S20170002

Drug Information

利妥昔单抗注射液

美罗华

注射剂

100 mg/10 ml

生物制品

April 28, 2017

Company Information

Applicant Company

Schonmattstrasse 2 4153 Reinach BL Switzerland

Manufacturing Company

Sandhoferstrasse 116 68305 Mannheim Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利妥昔单抗注射液 - NMPA 批准文号 | MedPath